Adjunctive aerosolized antibiotics for treatment of ventilator-associated pneumonia

Pharmacotherapy

Volumn 29, Issue 9, 2009, Pages 1054-1060

  Czosnowski, Quinn A ^a   Wood, G Christopher ^b   Magnotti, Louis J ^b   Croce, Martin A ^b   Swanson, Joseph M ^b   Boucher, Bradley A ^b   Fabian, Timothy C ^b  

^a UNIVERSITY OF THE SCIENCES   (United States)

^b UNIVERSITY OF TENNESSEE HEALTH SCIENCE CENTER   (United States)

Author keywords

Aerosolization; Amikacin; Antibiotics; Colistimethate; Colistin; Nebulization; Tobramycin; VAP; Ventilator associated pneumonia

Indexed keywords

AMIKACIN; AMINOGLYCOSIDE; AZTREONAM; CARBAPENEM; CEFEPIME; CIPROFLOXACIN; COLISTIMETHATE; MOXIFLOXACIN; PIPERACILLIN PLUS TAZOBACTAM; QUINOLINE DERIVED ANTIINFECTIVE AGENT; SULTAMICILLIN; TIGECYCLINE; TOBRAMYCIN; VANCOMYCIN;

ACINETOBACTER BAUMANNII; ADULT; AEROSOL; ARTICLE; BACTERIAL GROWTH; BACTERIUM ISOLATION; BODY TEMPERATURE; BRONCHOSPASM; CLINICAL ARTICLE; COLONY FORMING UNIT; CONTROLLED STUDY; DATA BASE; DRUG DELIVERY SYSTEM; DRUG SUBSTITUTION; DRUG WITHDRAWAL; FEMALE; HUMAN; INJURY SEVERITY; INTENSIVE CARE UNIT; LEUKOCYTE COUNT; LUNG INFILTRATE; LUNG LAVAGE; MALE; MEDICAL RECORD REVIEW; MONOTHERAPY; MULTIDRUG RESISTANCE; PSEUDOMONAS AERUGINOSA; THORAX RADIOGRAPHY; VENTILATOR ASSOCIATED PNEUMONIA;

ACINETOBACTER BAUMANNII; ADULT; AEROSOLS; AMIKACIN; ANTI-BACTERIAL AGENTS; APACHE; COLISTIN; CRITICAL ILLNESS; DRUG RESISTANCE, MULTIPLE; FEMALE; GLASGOW COMA SCALE; GRAM-NEGATIVE BACTERIA; HUMANS; MALE; MIDDLE AGED; PNEUMONIA, VENTILATOR-ASSOCIATED; PSEUDOMONAS AERUGINOSA; RETROSPECTIVE STUDIES; TOBRAMYCIN; TREATMENT OUTCOME;

EID: 69249084549     PISSN: 02770008     EISSN: None     Source Type: Journal    
DOI: 10.1592/phco.29.9.1054     Document Type: Article

References (27)

1. American Thoracic Society, Infectious Diseases Society of America. Guidelines for the management of adults with hospital-acquired, ventilator-associated, and healthcare-associated pneumonia. Am J Respir Crit Care Med 2005;171: 388-416. (Pubitemid 40227463)
2. Chastre J, Trouillet JL. Problem pathogens (Pseudomonas aeruginosa and Acinetobacter). Semin Respir Infect 2000;15:287-298
3. Fink MP, Snydman DR, Niederman MS, et al, for the Severe Pneumonia Study Group. Treatment of severe pneumonia in hospitalized patients: results of a multicenter, randomized, double-blind trial comparing intravenous ciprofloxacin with imipenem-cilastatin. Antimicrob Agents Chemother 1994;38: 547-557
4. Chastre J, Wolff M, Fagon JY, et al. Comparison of 8 vs 15 days of antibiotic therapy for ventilator-associated pneumonia in adults: a randomized trial. JAMA 2003;290:2588-2598 (Pubitemid 37443289)
5. Nicasio AM, Kuti JL, Nicolau DP. The current state of multidrug-resistant gram-negative bacilli in North America. Pharmacotherapy 2008;28:235-249
6. Wood GC, Swanson JM. Aerosolised antibacterials for the prevention and treatment of hospital-acquired pneumonia. Drugs 2007;67:903-914 (Pubitemid 46607390)
7. Klastersky J, Huysmans E, Weerts D, Hensgens C, Daneau D. Endotracheally administered gentamicin for the prevention of infections of the respiratory tract in patients with tracheostomy: a double-blind study. Chest 1974;65:650-654
8. Feeley TW, Du Moulin GC, Hedley-Whyte J, Bushnell LS, Gilbert JP, Feingold DS. Aerosol polymyxin and pneumonia in seriously ill patients. N Engl J Med 1975;293:471-475
9. Kwa AL, Loh C, Low JG, Kurup A, Tam VH. Nebulized colistin in the treatment of pneumonia due to multidrugresistant Acinetobacter baumannii and Pseudomonas aeruginosa. Clin Infect Dis 2005;41:754-757 (Pubitemid 41170367)
10. Berlana D, Llop JM, Fort E, Badia MB, Jodar R. Use of colistin in the treatment of multiple-drug-resistant gram-negative infections. Am J Health Syst Pharm 2005;62:39-47. (Pubitemid 40394633)
11. Mohr AM, Sifri ZC, Horng HS, et al. Use of aerosolized aminoglycosides in the treatment of gram-negative ventilatorassociated pneumonia. Surg Infect (Larchmt) 2007;8:349-357
12. Michalopoulos A, Fotakis D, Virtzili S, et al. Aerosolized colistin as adjunctive treatment of ventilator-associated pneumonia due to multidrug-resistant gram-negative bacteria: a prospective study. Respir Med 2008;102:407-412 (Pubitemid 351179979)
13. Croce MA, Fabian TC, Mueller EW, et al. The appropriate diagnostic threshold for ventilator-associated pneumonia using quantitative cultures. J Trauma 2004;56:931-934
14. Mueller EW, Croce MA, Boucher BA, et al. Repeat bronchoalveolar lavage to guide antibiotic duration for ventilator-associated pneumonia. J Trauma 2007;63:1329-1337
15. Wood GC, Mueller EW, Croce MA, Boucher BA, Hanes SD, Fabian TC. Evaluation of a clinical pathway for ventilator-associated pneumonia: changes in bacterial flora and the adequacy of empiric antibiotics over a three-year period. Surg Infect (Larchmt) 2005;6:203-213
16. Maragakis LL, Perl TM. Acinetobacter baumannii: epidemiology, antimicrobial resistance, and treatment options. Clin Infect Dis 2008;46:1254-1263
17. Lee NY, Lee HC, Ko NY, et al. Clinical and economic impact of multidrug resistance in nosocomial Acinetobacter baumannii bacteremia. Infect Control Hosp Epidemiol 2007;28:713-719
18. Tacconelli E, Tumbarello M, Bertagnolio S, et al. Multidrugresistant Pseudomonas aeruginosa bloodstream infections: analysis of trends in prevalence and epidemiology. Emerg Infect Dis 2002;8:220-221
19. Kollef MH, Sherman G, Ward S, Fraser VJ. Inadequate antimicrobial treatment of infections: a risk factor for hospital mortality among critically ill patients. Chest 1999;115:462-474 (Pubitemid 29083057)
20. Hamer DH. Treatment of nosocomial pneumonia and tracheobronchitis caused by multidrug-resistant Pseudomonas aeruginosa with aerosolized colistin. Am J Respir Crit Care Med 2000;162:328-330
21. Sobieszczyk ME, Furuya EY, Hay CM, et al. Combination therapy with polymyxin B for the treatment of multidrug-resistant gram-negative respiratory tract infections. J Antimicrob Chemother 2004;54:566-569 (Pubitemid 39177490)
22. Michalopoulos A, Kasiakou SK, Mastora Z, Rellos K, Kapaskelis AM, Falagas ME. Aerosolized colistin for the treatment of nosocomial pneumonia due to multidrug-resistant gram-negative bacteria in patients without cystic fibrosis. Crit Care 2005;9:R53-9.
23. Pereira GH, Muller PR, Levin AS. Salvage treatment of pneumonia and initial treatment of tracheobronchitis caused by multidrug-resistant gram-negative bacilli with inhaled polymyxin B. Diagn Microbiol Infect Dis 2007;58:235-240
24. Motaouakkil S, Charra B, Hachimi A, et al. Colistin and rifampicin in the treatment of nosocomial infections from multiresistant Acinetobacter baumannii. J Infect 2006;53:274-278
25. Klastersky J, Carpentier-Meunier F, Kahan-Coppens L, Thys JP. Endotracheally administered antibiotics for gram-negative bronchopneumonia. Chest 1979;75:586-591 (Pubitemid 9178586)
26. Miller DD, Amin MM, Palmer LB, Shah AR, Smaldone GC. Aerosol delivery and modern mechanical ventilation: in vitro/in vivo evaluation. Am J Respir Crit Care Med 2003;168:1205-1209 (Pubitemid 37421837)
27. Hedrick TL, Smith RL, McElearney ST, et al. Differences in early- and late-onset ventilator-associated pneumonia between surgical and trauma patients in a combined surgical or trauma intensive care unit. J Trauma 2008;64:714-720